Ignite
Tesamorelin
Body composition, transformed.
Order Inclusions
What it does for you
- /01Encourages your body to produce more of its own growth hormone, naturally
- /02Targets the stubborn fat stored around your organs, not just under the skin
- /03Helps balance cholesterol and fat levels in the blood
- /04Speeds up your resting metabolism so your body burns more at baseline
Batch Documentation
Tesamorelin Research Notes
What is Tesamorelin?
Tesamorelin is a synthetic analogue of growth hormone releasing hormone (GHRH) — the endogenous peptide that stimulates the pituitary gland to produce and release growth hormone. It is one of the few peptides in this category with a meaningful human clinical data record — it received FDA approval under the brand name Egrifta for HIV-associated lipodystrophy in 2010, making it one of the most clinically validated GHRH analogues available.
Unlike direct GH administration, tesamorelin stimulates the pituitary to produce GH in natural pulses — preserving the body's own feedback mechanisms rather than bypassing them.
What the research shows
Visceral fat reduction: Phase III trials in HIV-associated lipodystrophy showed significant reductions in visceral adipose tissue versus placebo over 26 weeks.
GH axis: Clinical studies consistently show elevated IGF-1 levels, confirming downstream activation of the GH axis.
Cognitive function: A randomised controlled trial in older adults with mild cognitive impairment (Baker et al., 2012) reported improvements in cognitive function versus placebo — an increasingly studied application.
Body composition: Clinical studies document improvements in the lean-mass-to-fat ratio alongside reductions in visceral fat.
Reference: Falutz J. et al. (2010). NEJM, 357(23), 2349–2361.
Ordering Tesamorelin in Bali
Tesamorelin is not a controlled substance under Indonesian BPOM regulations. Same-day delivery may be possible only after the team confirms the exact item, current availability, route, daily cutoff, complete villa or hotel address, and timing before ordering.
Common Questions
Q: How does tesamorelin differ from ipamorelin or CJC-1295?
Tesamorelin is a GHRH analogue that acts on the GHRH receptor. Ipamorelin is a GHRP that acts on the ghrelin receptor. CJC-1295 is also a GHRH analogue but has a longer half-life. Tesamorelin has the most extensive human clinical data of the three.
Q: Is it commonly stacked?
It is sometimes researched alongside ipamorelin for a dual-pathway GH stimulation protocol, with GHRH and GHRP acting on complementary receptors.
Q: Storage?
Refrigerate at 2–8°C. Use within 28 days of reconstitution. Ships cold-packed.
Research by goal
Explore Tesamorelin in context
Read the relevant goal guides to understand the research area, adjacent compounds, and the questions each track explores.